Bandaram Pharma Packtech Ltd (524602) — FY26 Annual Report | 1 September 2026

Bandaram Pharma Packtech Ltd (BSE: 524602) filed its 2026 annual report (Reg. 34 (1)) on 01.09.2026, announcing the rescheduled AGM for 24th September 2026 at 11:00 AM IST via Video Conferencing. The filing details AGM procedures, e-voting compliance, director appointments, financial performance, and governance. Key financials show standalone revenue of Rs. 1,095.99 lakhs (down from Rs. 1,222.83 lakhs), consolidated revenue of Rs. 6,292.32 lakhs (up from Rs. 3,696.37 lakhs), and a standalone net loss of Rs. 116.05 lakhs (vs. prior year's net profit of Rs. 14.00 lakhs). No dividend was recommended due to lack of profits. The company reappointed M/s M.M. Reddy & Co. as auditors at Rs. 200,000 annually and Mr. Suryaprakasa Rao Bommisetti as Independent Director for 5 years (2027-2032) at a proposed sitting fee of Rs. 75,000. Share capital increased from Rs. 12 Crores to Rs. 19 Crores authorized capital, with Rs. 597.19 Lakhs share premium recorded in reserves. The board maintained governance policies without changes, and no material changes occurred during the year.